Core Insights - BioLargo, Inc. announced the presentation of clinical experience with ViaCLYR™, an advanced wound irrigation solution, showcasing rapid wound transformation, enhanced healing, and strong antimicrobial performance across multiple wound types [1] Company Overview - BioLargo, Inc. is identified as a cleantech and life sciences innovator [1] Clinical Presentation - The clinical results were presented by Dr. Marcus Gitterle at the Boswick Symposium, highlighting a multi-site evaluation involving approximately 36 cases across four wound clinics over a four-month period [1]